SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-169343
Filing Date
2009-08-10
Accepted
2009-08-07 18:24:12
Documents
21
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 ALLERGAN, INC. FORM 10-Q d10q.htm 10-Q 1113731
2 EXHIBIT 10.18 dex1018.htm EX-10.18 6457
3 EXHIBIT 18 dex18.htm EX-18 2687
4 EXHIBIT 31.1 dex311.htm EX-31.1 7949
5 EXHIBIT 31.2 dex312.htm EX-31.2 8106
6 EXHIBIT 32 dex32.htm EX-32 7745
  Complete submission text file 0001193125-09-169343.txt   2863899

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT agn-20090630.xml EX-101.INS 499987
8 XBRL TAXONOMY EXTENSION SCHEMA agn-20090630.xsd EX-101.SCH 9564
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agn-20090630_cal.xml EX-101.CAL 40244
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agn-20090630_lab.xml EX-101.LAB 99402
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agn-20090630_pre.xml EX-101.PRE 76091
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10269 | Film No.: 09997063
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1